Five ‘Uncut Gems’ at U.S. Stock Exchange: An Investor Telegraph exclusive

Health is Wealth– This age-old adage will never be more worthy than for in the year 2020 for the global investor as COVID put the accelerator on the healthcare industry.

The diversity of the HEALTHCARE SECTOR was never so much visible as it has been in the last eight months. The mindset toward eating, insurance, fitness, preventive testing, and even shopping has radically changed, thanks to the coronavirus.

We are covering 5 uncut gems connected in some way or the other to the health sector which are likely to leave a mark on the U.S . stock markets in 2021.  The research team at Investor Telegraph is of the collective opinion that these stocks are promising over a period of 8- 12 months.

1. UnitedHealth Group ( UNH)

It is the largest healthcare company in the world by revenue, with a 2019 revenue of $242.2 billion. UnitedHealthcare revenues comprise 80% of the Group’s overall revenue and expansion of the company’s health services segment provides significant diversification benefits.

UnitedHealth remains well poised to benefit from its government business, comprising both Medicaid and Medicare Advantage. A solid balance sheet and consistent cash flow generation not only encourage investments in business but also add shareholder value.

At a value of around $320- 350, it is poised to cross 400 in the near future

2.    Bristol Myers Squibb ( BMY)

The Bristol Myers Squibb stock  ( BMY) is a good buying opportunity at the present time. BMY stock trades near $63 currently and it is, in fact, down 6% from its pre-Covid high of $67 in February 2020 – just before the coronavirus pandemic hit the world.

This pharma giant’s stock has rallied over 35% since its March lows of $46, compared to 63% gains for the S&P 500.

The stock is poised to accelerate in the coming year

3. Beyond Meat (BYND)

Beyond Meat (BYND)  is the maker of vegetable-based meat substitutes that have tapped into the zeitgeist of 2020 in a way that few other companies have matched. Thanks to a global rise of vegan and vegetarian diets, many consumers are eager to try the company’s meatless products.

The U.S. protein industry generates about $270 billion in annual sales. Globally, the number is about $1.4 trillion. The primary competition is with traditional meat, rather than other plant-based protein alternatives.

At $135 or more it may look overpriced but the industry is just warming up to the next generation of Vege- nonvegetarians. The uprising of this stock is certain in coming times.

4. Nomad  Foods (NOMD)

UK-based frozen foods company Nomad Foods (NOMD) has been a strong performer lately, with the stock up 1.8% in Sept this year. The stock hit a high of$ 26  and the company’s stock is up by  12 percent since the start of the year.

With the frozen food industry growing at a fast pace, the sluggish share movement is anticipated to accelerate for this European frozen-food giant in 2021.

At $ 25 a share, it is worth investing.

5. Quest Diagnostics Incorporated ( DGX)

As one of the U.S’s largest clinical laboratories,  Quest maintains collaborative agreements with various hospitals across the globe, offering access to diagnostic testing services for critical illnesses. Quest Diagnostics Incorporated (DGX) is a great stock when it comes to dividends but its recent performance is noteworthy.

It has a forward PE ratio (price relative to this year’s earnings) of just 12.32

The Medical – Outpatient and Home Healthcare industry will be a strong performer as the pandemic has changed people’s attitudes towards preventive healthcare and testing.

Its share price has risen by  68% in the last five years. At a price of $120, it falls into the buy category.